Literature DB >> 26627535

MicroRNAs and Endothelial (Dys) Function.

Gaetano Santulli1.   

Abstract

Accumulating evidence indicates that microRNAs (miRs)-non-coding RNAs that can regulate gene expression via translational repression and/or post-transcriptional degradation-are becoming one of the most fascinating areas of physiology, given their fundamental roles in countless pathophysiological processes. The relative roles of different miRs in vascular biology as direct or indirect post-transcriptional regulators of fundamental genes implied in vascular remodeling designate miRs as potential biomarkers and/or promising drug targets. The mechanistic importance of miRs in modulating endothelial cell (EC) function in physiology and in disease is addressed here. Drawbacks of currently available therapeutic options are also discussed, pointing at the challenges and clinical opportunities provided by miR-based treatments. J. Cell. Physiol. 231: 1638-1644, 2016.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26627535      PMCID: PMC4871250          DOI: 10.1002/jcp.25276

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  93 in total

1.  MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells.

Authors:  Dong Li; Pengyuan Yang; Qinghui Xiong; Xuhui Song; Xiangqun Yang; Lin Liu; Wenjun Yuan; Yao-Cheng Rui
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

Review 2.  The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.

Authors:  F Z Marques; S A Booth; F J Charchar
Journal:  J Hum Hypertens       Date:  2014-11-13       Impact factor: 3.012

Review 3.  Biological responses in stented arteries.

Authors:  Chiraz Chaabane; Fumiyuki Otsuka; Renu Virmani; Marie-Luce Bochaton-Piallat
Journal:  Cardiovasc Res       Date:  2013-05-10       Impact factor: 10.787

4.  MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation.

Authors:  Qinbo Yang; Chenglin Jia; Peiwei Wang; Minqi Xiong; Jingang Cui; Li Li; Wenjian Wang; Qingyu Wu; Yu Chen; Teng Zhang
Journal:  Int J Cardiol       Date:  2014-10-08       Impact factor: 4.164

5.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

Authors:  U Sigwart; J Puel; V Mirkovitch; F Joffre; L Kappenberger
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245

6.  Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Authors:  Stephen G Ellis; Dean J Kereiakes; D Christopher Metzger; Ronald P Caputo; David G Rizik; Paul S Teirstein; Marc R Litt; Annapoorna Kini; Ameer Kabour; Steven O Marx; Jeffrey J Popma; Robert McGreevy; Zhen Zhang; Charles Simonton; Gregg W Stone
Journal:  N Engl J Med       Date:  2015-10-12       Impact factor: 91.245

7.  Exploiting microRNA Specificity and Selectivity: Paving a Sustainable Path Towards Precision Medicine.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

8.  A Fleeting Glimpse Inside microRNA, Epigenetics, and Micropeptidomics.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

9.  MiR-492 impairs the angiogenic potential of endothelial cells.

Authors:  Francesca Patella; Eleonora Leucci; Monica Evangelista; Brian Parker; Jiayu Wen; Alberto Mercatanti; Milena Rizzo; Elena Chiavacci; Anders H Lund; Giuseppe Rainaldi
Journal:  J Cell Mol Med       Date:  2013-06-26       Impact factor: 5.310

10.  MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling.

Authors:  Shuihong Yao; Minmin Hu; Tingting Hao; Wan Li; Xue Xue; Min Xue; Xiaofei Zhu; Feng Zhou; Di Qin; Qin Yan; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

View more
  53 in total

Review 1.  Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular Diseases.

Authors:  Dipti Deshpande; David R Janero; Victor Segura-Ibarra; Elvin Blanco; Mansoor M Amiji
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

Review 2.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

Review 3.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  let-7 Contributes to Diabetic Retinopathy but Represses Pathological Ocular Angiogenesis.

Authors:  Qinbo Zhou; Robert J A Frost; Chastain Anderson; Fangkun Zhao; Jing Ma; Bo Yu; Shusheng Wang
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

5.  MicroRNA-217/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP+-induced SH-SY5Y cells.

Authors:  Mingda Wang; Hongming Sun; Yina Yao; Xicun Tang; Bo Wu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

6.  Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway.

Authors:  Jinming Zhu; Shichao Han
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 7.  MicroRNAs in the Pathobiology and Therapy of Atherosclerosis.

Authors:  Benoit Laffont; Katey J Rayner
Journal:  Can J Cardiol       Date:  2017-01-05       Impact factor: 5.223

8.  MicroRNAs Regulating Autophagy in Neurodegeneration.

Authors:  Qingxuan Lai; Nikolai Kovzel; Ruslan Konovalov; Ilya A Vinnikov
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.

Authors:  J Blauensteiner; R Bertinat; L E León; M Riederer; N Sepúlveda; F Westermeier
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

10.  Pathophysiological mechanisms underlying the beneficial effects of physical activity in hypertension.

Authors:  Jessica Gambardella; Marco Bruno Morelli; Xu-Jun Wang; Gaetano Santulli
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.